10 news items
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
ABBV
JNJ
LLY
21 May 24
or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
ABBV
CRBP
CRDL
14 May 24
Impacts
The rescheduling is likely to alleviate financial pressures on cannabis businesses, notably by eliminating certain tax burdens
Actinium Pharmaceuticals (NYSE: ATNM): A Prime Target in a Wave of Radiopharmaceutical Mergers and Acquisitions
ABBV
ATNM
AZN
8 May 24
or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content
Investment Opportunities in Biotech Amidst Federal Rate Uncertainties (ATNM)
ABBV
ATNM
AZN
22 Apr 24
informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article constitutes an offer
Actinium Pharmaceuticals (ATNM) Leads Biotech Innovation Amid Economic Uncertainty
ABBV
ATNM
AZN
19 Apr 24
a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice. No content in this article
1jizivip9le dlytpb4i9bbrayu3i79gcqnfddcrn4e
ABBV
12 Apr 24
for the first quarter of 2024 "are expected to include acquired IPR&D and milestones expense of $164 million on a pre-tax basis, representing
892egtk431cv1pzwuxco9vkgjvumdqs8
ABBV
12 Apr 24
quarter of 2024 "are expected to include acquired IPR&D and milestones expense of $164 million on a pre-tax basis, representing an unfavorable impact
r5rbggv0232qy0ag4d05mpvojbudv88aymvt54ab9ksk5i51y8rc7w
ABBV
10 Apr 24
that its earnings for the first quarter of 2024 "are expected to include acquired IPR&D and milestones expense of $164 million on a pre-tax basis
u9tbcuy4pogi06cvoy3zgm50zv53ax3
ABBV
26 Mar 24
to various factors.
The company has higher Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) of $3.85
viquge1dvux6aqdbyiyo0d5znh2ywykpx7qzvls1ycaqlx3abb1azen
ABBV
ANIX
BIIB
20 Mar 24
a recommendation to buy or sell a security. It is solely informational, and you should not construe it as legal, tax, investment, financial, or other advice
- Prev
- 1
- Next